Skip to main content
Premium Trial:

Request an Annual Quote

Sigma-Aldrich's Q3 Revenues, R&D Spend Rise 14 Percent as Profit Grows 5 Percent

NEW YORK (GenomeWeb News) — Sigma-Aldrich yesterday said third-quarter revenue rose 14 percent as R&D spending increased 14 percent and profit widened 5 percent.
 
Total receipts for the three months ended Sept. 30 increased to $503.2 million from $441.4 million year over year.
 
R&D spending increased to $15 million from $13.2 million year over year.
 
The company said profit increased to $71.6 million from $68.4 million in the year-ago period. 
 
Sigma-Aldrich said it had around $202.8 million in cash and equivalents as of Sept. 30.
 
The company said it expects organic sales to grow around 7 percent in the fourth quarter and for the full fiscal year.

The Scan

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.

Team Presents Cattle Genotype-Tissue Expression Atlas

Using RNA sequences representing thousands of cattle samples, researchers looked at relationships between cattle genotype and tissue expression in Nature Genetics.

Researchers Map Recombination in Khoe-San Population

With whole-genome sequences for dozens of individuals from the Nama population, researchers saw in Genome Biology fine-scale recombination patterns that clustered outside of other populations.

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.